Erudio Healtherudio.com
Indication
Anal cancer trials: what clinicians said in public
No HCP commentary report on a trial in anal cancer yet. Erudio has found public clinician commentary on 2 clinical trials in anal cancer: InterAACT 2 and TIRANUS. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| InterAACT 2 NCT04472429 · Incyte Corporation DeepView → | locally recurrent or metastatic squamous cell anal carcinoma | Phase 3 | Deep | View | |||
| TIRANUS NCT05661188 · Grupo Espanol Multidisciplinario del Cancer Digestivo FocusedView → | localized squamous cell carcinoma of the anal canal | Phase 2 | Focused | View | |||